Searchable abstracts of presentations at key conferences in endocrinology

ea0081p705 | Reproductive and Developmental Endocrinology | ECE2022

Lessons from a patient with the 48XXXY karyotype: Not just another case of Klinefelter’s syndrome

Kuzior Agnieszka , Hernandez-Lazaro Alba , de Leon-Durango Ricardo , Rios-Gomez Carlos , Arnas-Leon Claudia , Acosta-Calero Carmen , Maria Fernandez-Trujillo-Comenge Paula , Delia Santana-Suarez Ana , Gonzalez-Diaz Paula , Javier Martinez Martin Francisco

Introduction: The 48XXXY karyotype is an infrequent (incidence about 1/50000 male births) sporadic aneuploidy of the sex chromosomes, classically considered as a variant of the Klinefelter syndrome (47XXY). Although many of their characteristics are shared, patients with the 48XXXY karyotype suffer from additional endocrinological and neuropsychological disturbances which are not part of the classic Klinefelter syndrome. Hereby we present a clinical case.<p class="abstext"...

ea0081p506 | Late-Breaking | ECE2022

Initial results and patient satisfaction with the new oral formulation of semaglutide

Martinez Martin Francisco Javier , Kuzior Agnieszka , Arnas-Leon Claudia , Fernandez-Trujillo-Comenge Paula , Quintana-Arroyo Sara , Acosta-Calero Carmen , Delia Santana-Suarez Ana , Gonzalez-Diaz Paula , Hernandez-Lazaro Alba , de Leon-Durango Ricardo

Introduction: Oral semaglutide has been available in the Spanish market since November 2021. This new formulation has broken the self-injection barrier, and may enhance patient satisfaction.Methods: Retrospective review of the patients′ records and presential or telephonic interviews. All patients expressed their consent for the anonymous processing of their data. Numeric data are given as mean + s.d; paired t-test was used for comparison. Satisfac...

ea0090p808 | Late-Breaking | ECE2023

Effects of oral semaglutide on the lipid profile of patients with type 2 diabetes mellitus and obesity: Are they mediated by body weight loss?

Kuzior Agnieszka , Santana-Ojeda Borja , Jose de Leon-Durango Ricardo , Hernandez-Lazaro Alba , Rios-Gomez Carlos , Arnas-Leon Claudia , Acosta-Calero Carmen , Gonzalez-Diaz Paula , Maria Fernandez-Trujillo-Comenge Paula , Javier Martinez Martin Francisco

Introduction: It has been reported that patients with obesity and T2DM treated with oral semaglutide not only have a reduced total caloric input, but they also tend to reduce the proportion of fatty and sweet foodstuffs in an ad libitum diet. A modest improvement in the lipid profile of patients with obesity and T2DM treated with oral semaglutide has been reported, but its dependence on weight loss is not well established. We undertook to study the mediation effect of...

ea0090ep1105 | Late Breaking | ECE2023

Rechallenge with a single-pill combination of sitagliptin plus extended-release metformin in patients labelled as metformin-intolerant: Mostly successful

Javier Martinez Martin Francisco , Rios-Gomez Carlos , Santana-Ojeda Borja , Jose de Leon-Durango Ricardo , Hernandez-Lazaro Alba , Arnas-Leon Claudia , Acosta-Calero Carmen , Kuzior Agnieszka , Gonzalez-Diaz Paula , Maria Fernandez-Trujillo-Comenge Paula

Introduction: Extended-release (ER) metformin has been available in many countries for the last two decades, and it may have definite advantages vs. conventional (i.e., immediate-release) metformin: Reportedly, it may reduce gastrointestinal adverse effects by about half, thus increasing compliance; moreover, the once-a-day schedule may contribute to increased adherence and persistence, and hopefully improved outcomes. However, ER metformin was unavailable in Spain until 2022:...

ea0049ep174 | Endocrine tumours and neoplasia | ECE2017

Jejunum/ ileum Neuroendocrine Tumours: results of a multicentric retrospective study

Marques Ana Paula , Santos Ana Paula , Claro Isabel , Sanches Ana Cristina , Fernandes Isabel , Lopes Jose Manuel , Preto John , Rodrigues Fernando , Catarino Ana Luisa , Mellidez Juan , Pereira Bernardo , Rocha Gustavo , Bugalho Maria Joao , Neuroendocrinos Grupo Estudos Tumores

Introduction: The Neuroendocrine Tumors Study Group of the Portuguese Endocrine Society (SPEDM) performed the first observational study between November 2012 and July 2014 too assess the profile of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NET) patients (pts) followed at the main Portuguese hospitals. Several demographic and clinical data were collectedObjective: Characterize the clinicopathological features and treatment of patients with NET or...

ea0070aep1054 | Hot topics (including COVID-19) | ECE2020

A pilot trial for silymarin in prediabetic patients with preclinical liver disease: Focus on insulin resistance

Javier Martinez-Martin Francisco , Kuzior Agnieszka , Maria Fernandez-Trujillo-Comenge Paula , Hernandez-Lazaro Alba , Quintana-Arroyo Sara , Arnas-Leon Claudia , Acosta-Calero Carmen , Gonzalez Díaz Paula , Perdomo-Herrera Esperanza , Lucía Tocino-Hernandez Alba

Introduction: Silymarin is a standardized extract of the milk thistle (Sylibum marianum) seeds, containing a mixture of flavonolignans: silybinin, isosilybinin, silycristin, silydianin, and others. It is used in the treatment of toxic liver damage and as adjunctive therapy in chronic hepatitis and cirrhosis. Recent studies have shown a potential benefit in the treatment of diabetes mellitus and non-alcoholic fatty liver disease. We undertook to study the effect of silymarin on...

ea0056ep28 | Adrenal and Neuroendocrine Tumours | ECE2018

The infradiagnosis of primary aldosteronism as a public health problem

Martinez-Martin Francisco Javier , Gonzalez-Diaz Paula , Tocino-Hernandez Alba Lucia , Perdomo-Herrera Esperanza , Martin-Perez Marta , Santana-Suarez Ana Delia , Nivelo-Rivadeneira Manuel Esteban , Kuzior Agnieszka , Fernandez-Trujillo-Comenge Paula , Calero Carmen Acosta

Objectives: Understanding and propagating the knowledge of the burden caused by the massive infradiagnosis of Primary Aldosteronism (PA), partly due to unawareness of its high prevalence and partly to the complexity of its screening in Primary Care and workup in Specialized Care.Methods: Review of the relevant literature and personal reflections.Results: PA is the first cause of secondary hypertension and a highly prevalent disease...

ea0073pep15.8 | Presented ePosters 15: Late Breaking | ECE2021

Aggressive follicular thyroid carcinoma in a patient with Carney complex

Maria Fernandez-Trujillo-Comenge Paula , Hernandez-Lazaro Alba , de Leon-Durango Ricardo , Kuzior Agnieszka , Nivelo-Rivadeneira Manuel Esteban , Santana-Suarez Ana Delia , Arnas-Leon Claudia , Acosta-Calero Carmen , Gonzalez-Diaz Paula , Martinez-Martin Francisco Javier

IntroductionCarney Complex is a rare syndrome characterized by lentiginosis cutis and/or blue nevi, multiple endocrine neoplasia and non-endocrine tumors (cutaneous, mucosal, mammary or cardiac myxomata, bone osteochondromyxoma, psammomatous melanotic schwannoma, multiple ovarian cysts, multiple mammary ductal adenoma). Most cases are familiar, with autosomal dominant heredity and penetrance close to 100%. It is caused by a variety of mutations that acti...

ea0073aep431 | General Endocrinology | ECE2021

A giant GIST of the greater omentum in a female transsexual patient, hopefully not a side effect of hormonal therapy

Gonzalez-Diaz Paula , Leon-Durango Ricardo de , Hernandez-Lazaro Alba , Paula Maria Fernandez-Trujillo-Comenge , Kuzior Agnieszka , Acosta-Calero Carmen , Velazquez Yanina Elizabeth , Hernandez-Felipe Esther , Maria del Pino Perez-Garcia , Martinez-Martin Francisco Javier

IntroductionMany transsexual patients are concerned about the risk of cancer associated with hormonal gender-affirming therapy. However, the general risk seems to be very low. We hereby report the case of a strikingly large gastrointestinal stromal tumor (GIST) in a male-to-female transsexual patient, after 25 years of hormonal therapy.MethodsReview of the patientÂ’s clinical records and the relevant lite...

ea0073aep800 | Late Breaking | ECE2021

Vitamin D deficit in type 2 diabetes patients during the winter in Northern Gran Canaria with and without supplementation

Alba Hernández Lázaro , Paula María Fernandez-Trujillo-Comenge , Ricardo de Leon-Durango , Kuzior Agnieszka , Manuel Esteban Nivelo Rivadeneira , Carmen Acosta-Calero , Claudia Arnas-Leon , Sara Quintana-Arroyo , Paula Gonzalez-Diaz , Francisco Javier Martinez-Martin

IntroductionVitamin D deficiency is associated with higher risk of COVID-19, and type 2 diabetic patients are a vulnerable group. We described an alarming rate of vitamin D deficiency (81.0% < 30 ng/ml plasma calcifediol) in unsupplemented type 2 diabetes patients during the 2020 spring lockdown in Northern Gran Canaria. During the winter period (December 2020 to February 2021) some restrictions for social gatherings and a nightly curfew have been en...